Literature DB >> 7330671

Radiographic evaluation of therapeutic response in bony metastases of breast cancer.

H I Libshitz, G N Hortobagyi.   

Abstract

Response to chemotherapy was evaluated in 50 previously untreated patients with bony metastases of breast cancer. Lytic metastases respond in a definite sequence: sclerotic rim, filling-in, uniformly blastic, uniform fading. Increase in size of lytic areas of destruction in previously responding areas signals worsening. Mixed metastases are considered as beginning with a sclerotic rim. Response is otherwise similar. Particular attention is paid to the lytic areas. Blastic metastases are considered as beginning at the uniformly blastic stage. Progression is marked by a volumetric increase in blastic change or destruction in blastic regions. Change occurs slowly. Review of multiple studies is often necessary to reach the correct conclusion and clinical history is necessary.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7330671     DOI: 10.1007/bf00361858

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  10 in total

Review 1.  Medical treatment for advanced breast cancer.

Authors:  P P Carbone; T E Davis
Journal:  Semin Oncol       Date:  1978-12       Impact factor: 4.929

2.  Quantitative bone scanning: a method for assessing response of bone metastases to treatment.

Authors:  D L Citrin; R G Bessent; J B Tuohy; W R Greig; L H Blumgart
Journal:  Lancet       Date:  1974-06-08       Impact factor: 79.321

3.  The response to therapy of skeletal metastases from mammary cancer. Assessment by scintigraphy.

Authors:  C S Galasko; F H Doyle
Journal:  Br J Surg       Date:  1972-02       Impact factor: 6.939

4.  Limitations of bone scanning in clinical oncology.

Authors:  R K Loeffler; R N DiSimone; W J Howland
Journal:  JAMA       Date:  1975-12-22       Impact factor: 56.272

5.  Osseous metastases: radiographic monitoring of therapeutic response.

Authors:  J J Lokich
Journal:  Oncology       Date:  1978       Impact factor: 2.935

6.  Combination chemoimmunotherapy of metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, and BCG.

Authors:  G N Hortobagyi; J U Gutterman; G R Blumenschein; C K Tashima; M A Burgess; L Einhorn; A U Buzdar; S P Richman; E M Hersh
Journal:  Cancer       Date:  1979-04       Impact factor: 6.860

7.  Alternating noncross-resistant combination chemotherapy and active nonspecific immunotherapy with BCG or MER-BCG for advanced breast carcinoma.

Authors:  G R Blumenschein; G N Hortobagyi; S P Richman; J U Gutterman; C K Tashima; A U Buzdar; M A Burgess; R B Livingston; E M Hersh
Journal:  Cancer       Date:  1980-02-15       Impact factor: 6.860

8.  Ftorafur, adriamycin, cyclophosphamide and BCG in the treatment of metastatic breast cancer.

Authors:  G N Hortobagyi; G R Blumenschein; C K Tashima; A U Buzdar; M A Burgess; R B Livingston; M Valdivieso; J U Gutterman; E M Hersh; G P Bodey
Journal:  Cancer       Date:  1979-08       Impact factor: 6.860

9.  Assessment of response to therapy in advanced breast cancer (an amendment)

Authors:  J L Hayward; P P Carbone; R D Rubens; J C Heuson; S Kumaoka; A Segaloff
Journal:  Br J Cancer       Date:  1978-07       Impact factor: 7.640

10.  Assessment of response to therapy in advanced breast cancer.

Authors:  J L Hayward; P P Carbone; J C Heusen; S Kumaoka; A Segaloff; R D Rubens
Journal:  Br J Cancer       Date:  1977-03       Impact factor: 7.640

  10 in total
  9 in total

1.  Radiosurgery for metastatic spinal tumors: follow-up MR findings.

Authors:  Y J Hwang; M-J Sohn; B H Lee; S Y Kim; J W Seo; Y H Han; J Y Lee; S J Cha; Y H Kim
Journal:  AJNR Am J Neuroradiol       Date:  2011-10-27       Impact factor: 3.825

Review 2.  Basic concepts in metal work failure after metastatic spine tumour surgery.

Authors:  Naresh Kumar; Ravish Patel; Anshuja Charvi Wadhwa; Aravind Kumar; Helena Maria Milavec; Dhiraj Sonawane; Gurpal Singh; Lorin Michael Benneker
Journal:  Eur Spine J       Date:  2017-12-04       Impact factor: 3.134

3.  Osteodensitometry of vertebral metastases after radiotherapy using quantitative computed tomography.

Authors:  W D Reinbold; M Wannenmacher; N Hodapp; C P Adler
Journal:  Skeletal Radiol       Date:  1989       Impact factor: 2.199

4.  An objective biochemical assessment of therapeutic response in metastatic breast cancer: a study with external review of clinical data.

Authors:  M R Williams; A Turkes; D Pearson; K Griffiths; R W Blamey
Journal:  Br J Cancer       Date:  1990-01       Impact factor: 7.640

Review 5.  Imaging response to systemic therapy for bone metastases.

Authors:  Tobias Bäuerle; Wolfhard Semmler
Journal:  Eur Radiol       Date:  2009-05-26       Impact factor: 5.315

6.  Scintigraphic and radiographic patterns of skeletal metastases in breast cancer: value of sequential imaging in predicting outcome.

Authors:  M J Janicek; K Shaffer
Journal:  Skeletal Radiol       Date:  1995-11       Impact factor: 2.199

Review 7.  Molecular Pathogenesis and Diagnostic Imaging of Metastatic Jaw Tumors.

Authors:  Kenniyan Kumar Srichinthu; Arjun Parameshwar Raveendran; Periyasamy Tamilthangam; Joseph Joe; Charanya Duraisamy; Thukanayakanpalayam Ragunathan Yoithapprabhunath; Chitturi Ravi Teja
Journal:  J Pharm Bioallied Sci       Date:  2017-11

8.  Tumour response interpretation with new tumour response criteria vs the World Health Organisation criteria in patients with bone-only metastatic breast cancer.

Authors:  T Hamaoka; C M Costelloe; J E Madewell; P Liu; D A Berry; R Islam; R L Theriault; G N Hortobagyi; N T Ueno
Journal:  Br J Cancer       Date:  2010-01-26       Impact factor: 7.640

Review 9.  Multimodal imaging of bone metastases: From preclinical to clinical applications.

Authors:  Stephan Ellmann; Michael Beck; Torsten Kuwert; Michael Uder; Tobias Bäuerle
Journal:  J Orthop Translat       Date:  2015-08-13       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.